Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $1.1 million.

  • Catheter Precision's Cash & Equivalents fell 1538.46% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 1538.46%. This contributed to the annual value of $2.9 million for FY2024, which is 1941.09% down from last year.
  • As of Q3 2025, Catheter Precision's Cash & Equivalents stood at $1.1 million, which was down 1538.46% from $838000.0 recorded in Q2 2025.
  • Catheter Precision's Cash & Equivalents' 5-year high stood at $20.6 million during Q3 2021, with a 5-year trough of $16000.0 in Q2 2024.
  • Over the past 5 years, Catheter Precision's median Cash & Equivalents value was $7.4 million (recorded in 2023), while the average stood at $8.8 million.
  • As far as peak fluctuations go, Catheter Precision's Cash & Equivalents tumbled by 9978.41% in 2024, and later soared by 513750.0% in 2025.
  • Over the past 5 years, Catheter Precision's Cash & Equivalents (Quarter) stood at $15.0 million in 2021, then increased by 5.41% to $15.9 million in 2022, then tumbled by 77.52% to $3.6 million in 2023, then fell by 19.41% to $2.9 million in 2024, then tumbled by 61.71% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $838000.0 for Q2 2025, and $500000.0 during Q1 2025.